drugset / Trial / NCT03138317

Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis

NCT03138317 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Study was designed to evaluate efficacy of autologous platelet rich plasma (PRP) injections guided by ultrasound for treatment of knee osteoarthritis.

Timeline

Start
2017-01-02
Primary completion
2018-05-30
Completion
2018-05-30

Outcome

Missed primary endpoint

paper PRP and plasma were not superior to placebo for pain and function improvement in KOA over 24 weeks. PMID 34560869 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Unknown 6 ml Other
Subject Plasma Other / unclassified 6 ml Other

Indications